Autonomic Regulation in Prader-Willi Syndrome
Overview
To evaluate autonomic regulation in patients with Prader-Willi syndrome with sleep-disordered breathing.
Full Title of Study: “Impact of Sleep-disordered Breathing on Autonomic Regulation in Patients With Prader-Willi Syndrome”
Study Type
- Study Type: Observational [Patient Registry]
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: July 31, 2022
Detailed Description
To evaluate the relationship between narcolepsy and sleep-disordered breathing, the natural course of untreated or treated sleep-disordered breathing and its impacts on autonomic regulation in patients with Prader-Willi syndrome with sleep-disordered breathing.
Interventions
- Diagnostic Test: Polysomnography
- overnight polysomnography recording at least six hours
- Diagnostic Test: Multiple sleep latency test
- daytime naps at least four to five naps to evaluate daytime sleepiness and narcolepsy
- Other: Continuous positive airway pressure
- continuous positive airway pressure treatment for sleep-disordered breathing
Arms, Groups and Cohorts
- Control
- Healthy subjects, 7-75 y/o
- Study
- 7-75 y/o, diagnosed with Prader-Willi syndrome.
Clinical Trial Outcome Measures
Primary Measures
- Narcolepsy prevalence
- Time Frame: 1day
- Compare the narcolepsy prevalence amount healthy and Prader-Willi syndrome with or without sleep-disordered breathing
Secondary Measures
- The natural course and its impact of untreated sleep-disordered breathing on autonomic regulation in patients with Prader-Willi syndrome.
- Time Frame: 12 months
- Autonomic function measurements (low frequency power and high frequency power, presented as normalized units, and the overall autonomic regulation presented as Low frequency/high frequency ratio) using the EKG signal extracting from overnight polysomnography recording raw data among Prader-Willi patients with untreated sleep-disordered breathing at baseline and after a period of follow-up.
Participating in This Clinical Trial
Inclusion Criteria
- 7-75 y/o Prader-Willi syndrome patients or healthy subjects – can perform polysomnography, multiple sleep latency test – orthostatic methods for autonomic function test – can perform pulmonary function test. Exclusion Criteria:
- less than y/o, or larger then 75 y/o – cannot perform polysomnography, multiple sleep latency test – cannot orthostatic methods for autonomic function test – cannot perform pulmonary function test – use of sedatives or drugs affecting autonomic function
Gender Eligibility: All
Minimum Age: 7 Years
Maximum Age: 75 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- 美貞 楊, MD, Principal Investigator, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- Overall Contact(s)
- 美貞 楊, MD, 0970333784, mimimai3461@gmail.com
References
Ghergan A, Coupaye M, Leu-Semenescu S, Attali V, Oppert JM, Arnulf I, Poitou C, Redolfi S. Prevalence and Phenotype of Sleep Disorders in 60 Adults With Prader-Willi Syndrome. Sleep. 2017 Dec 1;40(12). doi: 10.1093/sleep/zsx162.
Sedky K, Bennett DS, Pumariega A. Prader Willi syndrome and obstructive sleep apnea: co-occurrence in the pediatric population. J Clin Sleep Med. 2014 Apr 15;10(4):403-9. doi: 10.5664/jcsm.3616.
Miller J, Wagner M. Prader-Willi syndrome and sleep-disordered breathing. Pediatr Ann. 2013 Oct;42(10):200-4. doi: 10.3928/00904481-20130924-10.
Clift S, Dahlitz M, Parkes JD. Sleep apnoea in the Prader-Willi syndrome. J Sleep Res. 1994 Jun;3(2):121-126. doi: 10.1111/j.1365-2869.1994.tb00115.x.
Scammell TE. Narcolepsy. N Engl J Med. 2015 Dec 31;373(27):2654-62. doi: 10.1056/NEJMra1500587. No abstract available.
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.